Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ALLO
#2713
Allogene Therapeutics, Inc. - Common Stock
1.9
8
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.50%
Monthly Change
+5.88%
6 month change
-22.35%
Year Change
+78.38%
Previous Close
1.9
9
Open
1.9
8
Low
1.9
8
High
1.9
8
Volume
74
Markets
US Stock Market
Healthcare
Biotechnology
ALLO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.07
Allogene Therapeutics, Inc. quarterly report, Q2 FY2024
10-Q
1
2
3
4
News
Allogene Therapeutics: Is The Market Looking At CAR-T Persistence The Wrong Way? (ALLO)
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
Allogene Therapeutics' Q2 Earnings Beat Estimates on Lower R&D Costs
Allogene Therapeutics, Inc. (ALLO) Q2 2026 Earnings Call Transcript
Upbit to list CYS, ICNT, XAN, EDEN, AIOZ, ALLO tokens on BTC and USDT markets
Allogene Therapeutics: High-Upside Bet On The Next Wave Of CAR-T Innovation (NASDAQ:ALLO)
Why Is Allogene Therapeutics (ALLO) Down 12.2% Since Last Earnings Report?
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q1
Allogene Therapeutics, Inc. (ALLO) Q1 2026 Earnings Call Transcript
Allogene Therapeutics Q1 2026 Earnings Call Transcript - Allogene Therapeutics (NASDAQ:ALLO)
Legend Biotech: Undervalued Leader In The CAR-T Race (NASDAQ:LEGN)
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study